Oncotarget

Research Papers:

Targeting of RET oncogene by naphthalene diimide-mediated gene promoter G-quadruplex stabilization exerts anti-tumor activity in oncogene-addicted human medullary thyroid cancer

Alessia Lopergolo _, Rosalba Perrone, Monica Tortoreto, Filippo Doria, Giovanni L. Beretta, Valentina Zuco, Mauro Freccero, Maria Grazia Borrello, Cinzia Lanzi, Sara N. Richter, Nadia Zaffaroni and Marco Folini

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2016; 7:49649-49663. https://doi.org/10.18632/oncotarget.10105

Metrics: PDF 2145 views  |   HTML 2016 views  |   ?  


Abstract

Alessia Lopergolo1,*, Rosalba Perrone2,*, Monica Tortoreto1, Filippo Doria3, Giovanni L. Beretta1, Valentina Zuco1, Mauro Freccero3, Maria Grazia Borrello1, Cinzia Lanzi1, Sara N. Richter2, Nadia Zaffaroni1, Marco Folini1

1Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133, Milano, Italy

2Department of Molecular Medicine, University of Padua, 35121, Padova, Italy

3Department of Chemistry, University of Pavia, 27100, Pavia, Italy

*These authors have contributed equally to this work

Correspondence to:

Marco Folini, email: marco.folini@istitutotumori.mi.it.

Sara N. Richter, email: sara.richter@unipd.it.

Keywords: gene promoter, G-quadruplex, medullary thyroid cancer, naphthalene diimide, RET oncogene

Received: October 22, 2015    Accepted: May 13, 2016    Published: June 16, 2016

ABSTRACT

Medullary thyroid cancer (MTC) relies on the aberrant activation of RET proto-oncogene. Though targeted approaches (i.e., tyrosine kinase inhibitors) are available, the absence of complete responses and the onset of resistance mechanisms indicate the need for novel therapeutic interventions. Due to their role in regulation of gene expression, G-quadruplexes (G4) represent attractive targets amenable to be recognized or stabilized by small molecules. Here, we report that exposure of MTC cells to a tri-substituted naphthalene diimide (NDI) resulted in a significant antiproliferative activity paralleled by inhibition of RET expression. Biophysical analysis and gene reporter assays showed that impairment of RET expression was consequent to the NDI-mediated stabilization of the G4 forming within the gene promoter. We also showed for the first time that systemic administration of the NDI in mice xenotransplanted with MTC cells resulted in a remarkable inhibition of tumor growth in vivo. Overall, our findings indicate that NDI-dependent RET G4 stabilization represents a suitable approach to control RET transcription and delineate the rationale for the development of G4 stabilizing-based treatments for MTC as well as for other tumors in which RET may have functional and therapeutic implications.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 10105